Metraipolis › archive › dc_e9cb781cfd8d

Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening — Europe PMC PMID:41007035

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007035
DOI
10.3390/children12091170
License (as archived)
solo-consultazione
Archived
2026-11-10T04:22:21.484Z
SHA-256 of the archived text
272bc214d80d00a44999b1e4d89d1b37b341aaeb7991441f951682ec469d5d0e
Stable URL of this page
https://metraipolis.com/documento/dc_e9cb781cfd8d

How to cite

Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening — Europe PMC PMID:41007035 — Europe PMC (en), https://europepmc.org/article/MED/41007035 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9cb781cfd8d (Metraipolis archive dc_e9cb781cfd8d, sha256 272bc214d80d00a44999b1e4d89d1b37b341aaeb7991441f951682ec469d5d0e)
BibTeX
@misc{dce9cb781cfd8d,
  title = {Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening — Europe PMC PMID:41007035},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007035},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9cb781cfd8d; sha256 272bc214d80d00a44999b1e4d89d1b37b341aaeb7991441f951682ec469d5d0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007035. Agents can read the archived copy with the MCP tool read_document.